Gene: FAM200A
Official Full Name: family with sequence similarity 200 member Aprovided by HGNC
Gene Summary: This gene encodes a protein of unknown function. The protein is weakly similar to transposase-like proteins in human and mouse. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27372 | FAM200A Knockout cell line (HeLa) | Human | FAM200A | 1:3~1:6 | Negative | Online Inquiry |
KO27373 | FAM200A Knockout cell line (HCT 116) | Human | FAM200A | 1:2~1:4 | Negative | Online Inquiry |
KO27374 | FAM200A Knockout cell line (HEK293) | Human | FAM200A | 1:3~1:6 | Negative | Online Inquiry |
KO27375 | FAM200A Knockout cell line (A549) | Human | FAM200A | 1:3~1:4 | Negative | Online Inquiry |
FAM200A Gene Knockout Cell Lines are innovative cellular models specifically designed to facilitate the study of FAM200A, a gene implicated in several critical cellular processes, including inflammation, cell signaling, and tumor progression. These engineered cell lines provide researchers with the ability to analyze the functional consequences of FAM200A depletion, enabling in-depth investigations into the gene's role in health and disease.
The key functionality of these knockout cell lines derives from the precise CRISPR/Cas9 genome-editing technology employed during their development. This technique introduces targeted mutations that effectively disrupt the FAM200A gene, leading to a complete loss of function. By utilizing these knockout models, scientists can conduct a range of assays to explore the gene's impact on cellular behavior, ranging from migration and proliferation to apoptosis and differentiation. Such insights are invaluable for elucidating the complexities of disease mechanisms and identifying potential therapeutic targets.
Scientifically, FAM200A Gene Knockout Cell Lines hold significant promise in research related to cancer, autoimmune diseases, and metabolic disorders. They are vital tools in preclinical studies, enabling the evaluation of drug responses and therapeutic interventions in a controlled environment that mimics disease conditions. Their application extends to both basic research settings and translational science, where they can contribute to the development of innovative treatments.
Compared to traditional cell models, FAM200A Gene Knockout Cell Lines offer unique advantages such as high specificity, reproducibility, and the capacity to model complex biological questions with greater fidelity. Researchers can achieve a more impactful understanding of gene function without the confounding variables present in wild-type cells, which may express additional compensatory pathways.
For researchers and clinicians, investing in FAM200A Gene Knockout Cell Lines translates to enhanced research capabilities and more reliable data that can inform experimental outcomes. This product allows professionals to advance their studies with confidence, knowing they are using cutting-edge, rigorously developed models.
Our company prides itself on its expertise in the field of genetic engineering and cell biology, delivering high-quality biological products tailored to the needs of the scientific community. By choosing our FAM200A Gene Knockout Cell Lines, you are not just acquiring a product; you are partnering with a market leader dedicated to supporting your research goals through innovation and excellence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.